All.Can International is currently looking to recruit a Chief Executive Officer (CEO) to lead the initiative into an exciting new phase.
At the 4th Biennial World Summit of Brain Tumour Patient Advocates Suzanne Wait, shared findings from the All.Can patient survey with participants, focusing on findings specific to patients with brain/central nervous system (CNS) tumours.
On 2 October 2019 All.Can international sent a letter to Stella Kyriakidou welcoming her unique perspective in the field of health, and sharing key findings from the All.Can patient survey.
All.Can is delighted to welcome Roche as a new funding member of the international initiative.
Since All.Can was established, its work has gained coverage in a number of magazines, websites and newspapers.
The All.Can international blog features guest posts from leading figures in cancer care across Europe.
Explore the All.Can international newsletter archives, dating back to the first issue from March 2017.